Location History:
- Goettingen, DE (2009 - 2010)
- Gottingen, DE (2012 - 2022)
- Göttingen, DE (2010 - 2024)
Company Filing History:
5 out of 300 
4 out of 4 
2 out of 3,226 
Years Active: 2009-2024
Title: Dieter Melzner: Innovator in Lateral Flow Technology
Introduction
Dieter Melzner is a prominent inventor based in Göttingen, Germany. He has made significant contributions to the field of lateral flow technology, holding a total of 11 patents. His work focuses on developing innovative solutions for multiparameter readouts and immunoassay devices.
Latest Patents
Among his latest patents, Melzner has developed a lateral flow membrane designed for multiparameter readouts. This invention features a microporous membrane layer supported on a liquid-impermeable support layer, allowing for the lateral flow of liquid through the membrane. The design includes two or more flow lanes separated by hydrophobic separation channels, each containing a detection spot with a binding agent. Additionally, he has created a compact multiparameter lateral flow immunoassay device that utilizes this advanced membrane technology. Another notable patent is a patterned membrane structure that comprises a microporous membrane layer with a repetitive pattern of flow lanes and hydrophobic separation channels, which serves as an industrial-scale precursor for multiparameter lateral flow membranes.
Career Highlights
Dieter Melzner has worked with several notable companies in the biotechnology sector, including Sartorius Stedim Biotech GmbH and Elcomax Membranes GmbH. His experience in these organizations has contributed to his expertise in membrane technology and immunoassays.
Collaborations
Throughout his career, Melzner has collaborated with talented professionals, including Annette Reiche and Suzana Kiel. These partnerships have further enhanced his innovative capabilities and contributions to the field.
Conclusion
Dieter Melzner is a distinguished inventor whose work in lateral flow technology has led to significant advancements in multiparameter readouts and immunoassay devices. His numerous patents and collaborations reflect his commitment to innovation in the biotechnology industry.